Celltex Therapeutics Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
36
- Latest Deal Type
-
Debt - PPP
- Latest Deal Amount
-
$725K
Celltex Therapeutics General Information
Description
Provider of proprietary stem cell processing and banking system intended to improve the quality of life for those suffering from a range of degenerative, autoimmune, and vascular conditions. The company specializes in banking one's own mesenchymal stem cells (MSCs) for therapeutic use to ensure the genetic integrity and uniformity of an individual's cells, allowing individuals of all ages to obtain a medically-beneficial dose of their own stem cells.
Contact Information
Website
www.celltexbank.comCorporate Office
- 2401 Fountain View Drive
- Suite 416
- Houston, TX 77057
- United States
Corporate Office
- 2401 Fountain View Drive
- Suite 416
- Houston, TX 77057
- United States
Celltex Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Debt - PPP | 05-Apr-2020 | $725K | Completed | Generating Revenue | ||
2. Secondary Transaction - Private | 01-Jun-2019 | Completed | Generating Revenue | |||
1. Early Stage VC | 03-Jul-2012 | $34.1M | $34.1M | Completed | Generating Revenue |
Celltex Therapeutics Comparisons
Industry
Financing
Details
Celltex Therapeutics Competitors (16)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Allogene Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
Human Longevity | Venture Capital-Backed | San Diego, CA | ||||
Garuda Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
Mammoth Biosciences | Venture Capital-Backed | Brisbane, CA | ||||
Egenesis | Venture Capital-Backed | Cambridge, MA |
Celltex Therapeutics Executive Team (3)
Name | Title | Board Seat |
---|---|---|
David Eller | Co-Founder, Chief Executive Officer & Chairman of the Board | |
Jane Young Ph.D | Chief Scientific Officer | |
Stanley Jones MD | Co-Founder, Chief Medical Officer & Board Member |
Celltex Therapeutics Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
Anita Perry | Self | Board Member | |
David Coolidge | Self | Board Member | |
David Eller | Celltex Therapeutics | Co-Founder, Chief Executive Officer & Chairman of the Board | |
Lawrence Samuels | Self | Board Member | |
Nabil Sakkab | Self | Board Member |
Celltex Therapeutics Signals
Celltex Therapeutics FAQs
-
When was Celltex Therapeutics founded?
Celltex Therapeutics was founded in 2011.
-
Who is the founder of Celltex Therapeutics?
David Eller and Stanley Jones MD are the founders of Celltex Therapeutics.
-
Who is the CEO of Celltex Therapeutics?
David Eller is the CEO of Celltex Therapeutics.
-
Where is Celltex Therapeutics headquartered?
Celltex Therapeutics is headquartered in Houston, TX.
-
What is the size of Celltex Therapeutics?
Celltex Therapeutics has 36 total employees.
-
What industry is Celltex Therapeutics in?
Celltex Therapeutics’s primary industry is Other Healthcare Technology Systems.
-
Is Celltex Therapeutics a private or public company?
Celltex Therapeutics is a Private company.
-
What is Celltex Therapeutics’s current revenue?
The current revenue for Celltex Therapeutics is
. -
How much funding has Celltex Therapeutics raised over time?
Celltex Therapeutics has raised $34.1M.
-
Who are Celltex Therapeutics’s competitors?
Allogene Therapeutics, Human Longevity, Garuda Therapeutics, Mammoth Biosciences, and Egenesis are some of the 16 competitors of Celltex Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »